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SUMMARY
The airway diseases asthma, chronic bronchitis and emphysema all share
as a main characteristic shortness of breath, which is the result of airway
obstruction. The parasympathetic (cholinergic) nervous system, being the
major bronchoconstrictor neural pathway in (human) airways, has therefore
been implied in both the pathogenesis and the therapy of these disease
states. The effects of the cholinergic nervous system on target cells in the
airways (smooth muscle, exocrine glands, blood vessel walls) are elicited
via release of acetylcholine, which binds to muscarinic type receptors on
the target cells. The present thesis deals with investigations concerning
binding properties, transductional properties as well Írs functional
properties of these muscarinic receptors in airway smooth muscle (in
comparison with cardiac and brain tissue), in view of the notion emerged
during the past decade that muscarinic receptors can be distinguished into
discrete subtypes.
In the first part of the thesis (Chapters 2-5), the discovery of the
presence of a majority of M2 (cardiac type) as well as a minority of M3
(smooth muscle/glandular type) muscarinic binding sites in bovine tracheal
smooth muscle membranes is described. Init ially it was found that the
binding properties of pirenzepine towards muscarinic receptors in bovine
cardiac and tracheal membranes agreed very well with affinit ies reported
in functional experiments using mainly guinea pig tissues (low affinity in
all cases), but that this was not the case for AF-DX I 16. In cardiac
membranes,  the AF-DX l l6  b inding af f in i ty  was re lat ive ly  h igh (Ka = 96
nM) in agreement with reported functional affinit ies (M1 receptor subtype).
However, in tracheal membranes trvo binding sites could be distinguished,
of which the majority (740/o) had high (Mr, heart-l ike) affinity and the
minor i ty  low (N13,  g land- l ike)  af f in i ty  for  AF-DX I16.  Since these
membranes had been prepared from bovine tracheal smooth muscle with
intact epithelium and submucosa, it was suggested that the minority of low
affinity muscarinic binding sites represented glandular muscarinic receptors,
the majority of high affinity binding sites presumably representing smooth
muscle muscarinic receptors (Chapter 2). The binding properties of AF-DX
ll6 in bovine tracheal membranes were especially important because they
predicted discrepancies between binding and functional properties for
muscarinic receptors in smooth muscle, contraction being mediated by the
M3 subtype. This was further investigated in Chapter 3. It was established
that  funct ional  af f in i t ies of  muscar in ic  antagonists  (AF-DX l16 and s ix
others) in bovine tracheal smooth muscle correlated extremely well with
those reported for guinea pig smooth muscle preparations, suggesting
discrepancies between binding and functional properties of muscarinic
antagonists in bovine tracheal smooth muscle rather than species differen-
ces. These, occasionally marked, discrepancies between binding and
function indeed appeared to be present with all compounds tested.
However, in contrast to the non-selective (atropine, pirenzepine) and
smooth muscle selective antagonists (4-DAMP methobromide, hexahydro-
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si ladi fenidol ) ,  u ,h ich gave monophasic d isp lacement  cur i 'es wi th M'- l ike
af f in i t ies,  the card ioselect ive antagonists  AF-DX I  16,  gal lamine and
methoctramine st i l l  d is t inguished a major i ty  of  Mr- l ike and a minor i ty '  o f
M3- l ike b inding s i tes,  a l though the membranes had been prepared using
bovine t racheal  smooth rnuscle fu l ly  denuded of  epi thel ium and submucosa
( i .e .  no exocr ine g lands present) .  These resul ts  suggested that  in  smooth
muscle membranes only a smal l  proport ion of  the muscar in ic  b inding s i tes
is involved in cont.raction, but the rather clear quantitative differences
between pA2 values for contraction and pI(1 values for binding to the
minor i t -v  of  M3- l ike b inding s i tes as wel l  as the presence of  the major i ty
of  M'  type b inding s i tes prec luded a def in i te  conclus ion.
The s imul taneous occurrence of  M2 and M3 type muscar in ic  b inding
sitcs in bovine tracheal smooth muscle could also be demonstrated using a
k inet ic  approach,  i .e .  radio l igand d issociat ion measurements (Chapter  4) .  I t
appeared that  [ rH]dexet imide d issociat ion f rom muscar in ic  receptors in  th is
t issue was b iphasic,  wi th a fast  phase (hal f * l i fe  < I  min)  fo l lowed af ter  4-
5 min by a slor,,, phase (half-l i fe - 40 min). The fast phase was shor.r'n to
represent  the card iac t ] ,pe receptors in  bovine t racheal  smooth muscle
because ( i )  a  s imi lar  d issociat ion hal f - l i fe  was found for  [3H]dexet imide in
bovine card iac le f l  r 'cnt r icu lar  membranes,  ( i i )  the re lat ive proport ion of
muscar in ic  b inding s i tes in  bovine t racheal  smooth muscle exhib i t ing th is
fast  d issociat ion behaviour  agreed wi th the proport ion of  card iac (Mr)
muscar in ic  s i tes as detected in  equi l ibr ium binding studies,  and ( i i i )  a
v i r tual l f  ident ica l  a l loster ic  (negat ive cooperat ive)  modulat ion of  radio-
l igand d issociat ion f rom M1 muscar in ic  receptors in  bovine card iac and
[racheal  smooth muscle membranes by AF-DX 116,  gal lamine and methoc-
t ramine was observed.  The s low phase was concluded to represent  the
smooth muscle/g landular  type receptors in  th is  t issue based on i ts  re lat ive
proport ion (30V0) and compar ison to [ rH]N-methylscopoiamine d issociat ion
behaviour  in  card iac and g landular  membranes (as repor ted bv others) .  l t
was concluded that  the M2 type muscar in ic  b inding s i tes in  bovine t racheal
smooth muscle membranes resemble M2 musc?rinic receptors in cardiac
membranes noI  only  regarding equi l ibr ium binding af f in i t ies but  a lso
regarding radioligand dissociation and allosteric modulation. Moreover, M-,
type binding sites in bovine tracheal smooth muscle appeared much iess
sensi t ive to a l loster ic  modulat ion than the card iac receptor  subtype.  Thc
studies concerning the M2 and M3 muscar in ic  b inding s i tes in  (bovine
tracheal)  smooth muscle were completed wi th Chapter  5.  Using cornpuÍ .er
f i t t ing and s imulat ion procedures,  i t  was shown that  the presumed non*
selcct ive muscar in ic  radio l igand appl ied in  our  exper iments,  [ rH]dexet imidc,
actual ly  possesses a smal l  (about  6- fo ld)  se lect iv i ty  for  M3 over  M2
receptors. 'Ihe assumption of non-selecÍ.ivity of this radioligand (as in
Chapters 2 and 3) was shown to result in erroneous estimates of binding
parameters for  card ioselect ive muscar in ic  antagonists ,  and the smal l
radioligand selectivity actuaily present was shown to lead to an inabil ity to
detect both M, and M3 receptor populations using smooth rnuscle selective
muscarinic antagonists with selectivit ies less than 30-fold. Using fore-
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knowledge acquired with the cardioselective compounds, however, the
monophasic displacement curves obtained with the smooth muscle selective
antagonists could be resolved into high (Ms) and low (Mz) affinity
populations. As a consequence of the findings in Chapter 5, all results
obtained in Chapters 2-4 could be accomodated into the model that smooth
muscle membranes contain a majority of M2 (cardiac) and a minority of M3
(smooth muscle/glandular) type binding sites, the latter representing the
receptors involved in smooth muscle contraction.
The second part of the thesis (Chapters 6-8) presents investigations on
the recognition by classical quaternary muscarinic antagonists (l ike
ipratropium, N-methylscopolamine and oxyphenonium bromide) of two
discrete binding sites, as init ially observed in calf and rat brain tissue. It
was found that this binding heterogeneity, which we have called Q1/Q2,
occurs in bovine striatal membranes in a manner similar to bovine total
brain membranes, indicating that the high (Qr) and low (Q2) affinity
binding populations do not originate from different brain areas (Chapter 6).
It was also found that the Qr/Qz binding heterogeneity is independent of
the pirenzepine binding heterogeneity (M1/M2). In search of the peripheral
tissue distribution of the Qt/Qz binding heterogeneity it was established
that quaternary muscarinic antagonists also distinguish the two classes of
binding sites in bovine tracheal smooth muscle membranes but not in
bovine cardiac (atrial and ventricular) membranes. The findings from
Chapter 6 were extended by investigating the molecular basis of the Q1/Q2
binding heterogeneity (Chapter 7) and the possible functional consequences
of this binding behaviour in bovine tracheal smooth muscle contraction
(Chapter 8). Using agents that are known to modulate (muscarinic)
receptor  b inding (Na+ and Mg2*,  GppNHp, d i th iothre i to l ,  N-ethy lmale imide) ,
no indications were obtained that the Q1 and Q2 binding site populations
are molecularly different muscarinic receptor subtypes since they were not
differentially modulated by these agents. Using membrane modulating
agents (sodium laurylsulfate, digitonine, polyethylene glycol 6000,
cholesteryl hemisuccinate), no evidence was obtained either that the low
affinity (Qz) binding sites represent muscarinic receptors located in a
different membrane environment less accessible to (charged) quaternary
compounds, since these agents did not bring about changes in the
appearance of the heterogenous binding behaviour. However, a qualitative
correlation could be observed between the octanol:buffer partit ion
coefficients (as a measure of l ipid solubil ity) and the appearance of Q1/Q2
binding heterogeneity for six quaternary muscarinic antagonists and
therefore the low affinity binding sites may after all be (normal) mus-
carinic receptors located in a hydrophobic membrane domain (Chapter 7).
In bovine tracheal smooth muscle contraction experiments, some quater-
nary muscarinic antagonists showed anomalous behaviour as well. When
antagonizing methacholine-induced contraction, ipratropium, N-
methylscopolamine, oxyphenonium, and N-methyldeptropine bromide gave
Schild plots with slopes significantly greater than unity (up to 2.O),
indicating uncompetit ive interaction. By contrast, the tertiary analogues
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atropine and scopolamine as u 'e l l  as two other  quaternary compounds,  4-
DAMP methobromide and th iaz inamium, behaved as c lass ical  anlagonists
u ' i th  Schi ld  s lopes of  uni ty ,  as d id iprat ropium and N-meth,v ldeptropine in
guinea p ig t rachea.  The h igh Schi ld  p lot  s lopes in  bovine t racheal  smooth
muscle were found not  to  be due to inadequate equi l ibrat ion of  the
antagonists  or  to  the presence of  an at ropinesterase in the t issue.  but
posi t ive cooperat iv i ty  of  the quaternary muscar in ic  antagonists  was shown
to be the under ly ing mechanism instead (Chapter  8) .  I t  should be men-
t ioned that  apparent ly '  no re lat ionship ex is ts  between heterogeneous b inding
behaviour  of  c lass ical  quaternary muscar in ic  antagonists  and posi t ivc
cooperat iv i ty  in  contract ion studies,  s ince N-methyldeptropine gave the
highest  Schi ld  p lot  s lopcs (Chapter  8)  but  d id not  exhib i t  Qr/Qz b inding
heterogenei ty  (Chapter  7) .
In  the th i rd and last  par t  of  the thesis  (Chapters 9- l l ) ,  exper iments
are descr ibed concerning the t ransduct ion mechanism(s)  coupled to
muscarinic receptors in bovine tracheal smooth rnuscle as r,l ell as the
character izat ion of  the muscar in ic  receplor  subtype mediat ing contract ion
of  hwrnn a i rway'  smooth muscle.  In  Chapter  9,  the re lat ionship between
bovine t racheal  smooth muscle contract ion and phosphoinosi t ide metabol ism
was studied us ing muscar in ic  agonists .  I t  was establ ished that  wi th a l l
three agonists  used,  methachol ine (non-select ive) ,  McN-A -343 (M r-
select ive) ,  oxotremor ine (M7-select ive) ,  500/o contract ion was e l ic i tcd by
concentrat . ions u 'h ich only gave 3.So/ct  of  the maximal  at ta inable inosi to l
phosphates accumulat ion,  ind icat ing ( i )  a  considerable reserve of  inosi to l
phosphates product ion for  the fu l l  contract i le  agonists  methachol inc and
oxotremor inc,  and ( i i )  a  d i rect  re lat ionship between phosphoinosi t idc
mctabol ism and smooth muscle contract ion.  such a d i rect  re lat ionship
could a lso be concluded f rom Chapter  10,  u,here the muscar in ic  receptor
subtvpe mcdiat ing phosphoinosi t ide metabol ism in bovine t racheal  smooth
muscle was pharmacological l f  ident i f ied us ing the compet i t ive antagonists
p i renzep ine  (Mr -se l cc t i ve ) ,  AF -DX 116  (Mr -se lec t i ve ) ,  and  4 -DAMP
methobromide (M3-select ive) .  The M3 character  found in these exper iments
coinc ided wi th the M3 muscar in ic  receptor  subt l 'pe rnediat ing smoolh
muscle contract ion and thus provided addi t ional  ev idence for  the involve-
ment  oÍ '  phosphoinosi t ide met ,abol ism in the pharmacomechanical  coupl ing
between muscar in ic  receptor  s t imulat ion and contract ion of  (bovine
tracheal)  smooLh muscle.  Hence,  the funct ion of  the major  populat ion of
card iac type (M2) nruscar in ic  receptors and the t . ransduct ion mechanism
involved remain to be e luc idated.
As a "Grandc Finale" ,  the thesis  c loses wi th the character izaí ion of  the
muscar in ic  receptor  subtype involved in contract ion of  human ai rw.ay
smooth muscle (Chapter  I  I  ) "  I t  was found,  us ing a Schi ld  analys is  wi th f ive
select.ive muscarinic antagonists, that contraction of human peripheral
(small bronchi) and central (trachea) airway smooth muscle is mediated tr_v
the M, muscar in ic  receptor  subtype,  just  as is  the case wi th bovine anci
guinea pig tracheal smooth rnuscle. These animal t issues therefore provide
excel lent  models for  the development  of  M,  subt l 'pe-select ive muscar in ic
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antagonists to be used as bronchodilators free of M2-(cardiac or auto-
receptor) blocking properties.
In conclusion, the studies described in this thesis have contributed
significantly to the increasing knowledge on muscarinic receptor subtypes
over the past years, especially concerning (airway) smooth muscle'
Important questions remaining include the function of the M2 receptors in
smooth muscle and the extrapolation of selected findings to human (airway)
smooth muscle, especially regarding the presence of M2 receptors and the
relationship betu'een phosphoinositide metabolism and contraction.
Subsequently, studies on the possible disturbance of (pre- and postjunc-
tional) muscarinic receptor mechanisms in obstructive airway disease are at
hand.
225
